RecruitingNCT06448455

Observation on the Frailty Status of Lung Cancer Patients

Observation of Frailty in Lung Cancer Patients and Its Influencing Factors

Sponsor

Peking University Third Hospital

Enrollment

200 participants

Start Date

Apr 1, 2024

Study Type

OBSERVATIONAL

Conditions

Lung Cancer

Summary

Using the Integrated Conceptual Model of Frailty (ICMF) and Frailty Framework among Vulnerable Population (FFVP) as theoretical basis, the frailty status of lung cancer patients is described, and the physiological, psychological, and social frailty of lung cancer patients are comprehensively evaluated and analyzed. The influencing factors related to frailty are explored, in order to provide a basis for effective intervention research on lung cancer patients in the future.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study monitors the level of frailty in people with lung cancer to better understand how weakness and vulnerability affect their overall health and cancer treatment outcomes. Participants will complete questionnaires and assessments. **You may be eligible if...** - You are 18 or older - You have been diagnosed with lung cancer (confirmed by pathology or cytology) - You are able to complete a questionnaire independently or with researcher guidance **You may NOT be eligible if...** - You have serious organ failure (heart, lung, or kidney) - You have a history of dementia, mental illness, or cognitive impairment - You are blind, deaf, or aphasic - You are currently enrolled in another study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.